Key result
Remote monitoring of ICDs was not associated with achieving an effective dose of beta-blockers at 12 months compared to standard follow-up (16% vs 20%), though both independently improved outcomes.
Why the study?
Does remote monitoring of ICDs improve beta-blocker utilization and clinical outcomes in heart failure patients?
Observational (n=987)
Yes
Does remote monitoring of ICDs improve beta-blocker utilization and clinical outcomes in heart failure patients?
Absolute Event Rate: 16% vs 20%
In real-world heart failure patients with ICDs, remote monitoring does not increase the likelihood of achieving effective beta-blocker doses, though both remote monitoring and optimal beta-blocker dosing independently improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Remote monitoring should not guide beta-blocker optimization in ICD patients; leaves open whether combined strategies yield additive benefit.
D’Onofrio et al. (2015) conducted an observational in Heart failure with implantable cardioverter defibrillators (n=987). Remote monitoring vs. Standard follow-up was evaluated on Effective dose of beta-blockers at 12 months. Remote monitoring of ICDs was not associated with achieving an effective dose of beta-blockers at 12 months compared to standard follow-up (16% vs 20%), though both independently improved outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: